辰林教育(01593.HK)全年經調整純利升23.0%至1.23億元 末期息1.88分
格隆匯3月31日丨辰林教育(01593.HK)公佈,截至2019年12月31日止年度,集團實現收益2.51億元人民幣(單位下同),同比增長16.8%;毛利1.71億元,同比增長11.7%;年內溢利8357萬元,同比增長0.4%;經調整純利1.23億元,同比增長23.0%;每股基本盈利0.12元,擬派末期股息每股0.0188元。
於2019年╱2020年學年,集團新入學學生總數為4825人,較2018年╱2019年學年增加約11.0%;於2019年╱2020年學年,集團本科專業及專科專業的平均學費較2018年╱2019年學年分別增加約21.0%及14.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.